This page highlights the top published articles in the field of COVID19 and cardiovascular diseases.

Link: The COVID Inpatient Risk Calculator: CIRC

Information on COVID19:

NIH COVID-19 Resources

The LANCET: COVID-19 Resource Center

The NEJM: COVID-19 Resource Center

NEJM Journal Watch: COVID-19 Page

Cell Press Coronavirus Resource Hub

19.02.2023: Recent  original articles

Shedding Light on Mechanisms of Myocarditis with COVID-19 mRNA Vaccines

Acute Cardiac Events during COVID-19-Associated Hospitalizations

16.11.2022: Recent  original articles

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in macaques

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection

Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: A self-controlled case series study

Lifting Universal Masking in Schools — Covid-19 Incidence among Students and Staff

Cognitive Deficits in Long Covid-19

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

07.10.2022: Recent  original articles

Myocarditis Following SARS-CoV2 mRNA Vaccination against COVID-19: Facts and Open Questions. Cardiovascular Medicine and Society

01.09.2022: Recent  original articles

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT

24.08.2022: Recent  original articles

Risk of Myocarditis after Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex

15.08.2022: Recent  original articles

Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study

02.08.2022: Recent  original articles

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review

Burnout and resilience during the COVID-19 outbreak: differences between male and female students

Prediction of hospital-onset COVID-19 infections using dynamic networks of patient contact: an international retrospective cohort study

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

22.07.2022: Recent  original articles

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults

Association of Blood Viscosity with Mortality Among Patients Hospitalized With COVID-19

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards

08.07.2022: Recent  original articles

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

28.06.2022: Recent  original articles

Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards

10.06.2022: Recent  original articles

Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology

02.06.2022: Recent  original articles

Long COVID after breakthrough SARS-CoV-2 infection

The performance of wearable sensors in the detection of SARS-CoV-2 infection

Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data.

Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

11.04.2022: Recent  original articles

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis

Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform

31.03.2022: Recent  original articles

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

BNT162b2 Protection against the Omicron Variant in Children and Adolescents

Effect of Early Treatment with Ivermectin among Patients with Covid-19

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study

16.03.2022: Recent  articles

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

18.02.2022: Recent  articles

A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant

21.01.2022: Recent  articles

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

11.01.2022: Recent  articles

Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID program

NEJM: Rapid Diagnostic Testing for SARS-CoV-2

06.01.2022: Recent Omicron articles

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

The rapid spread of the Omicron VOC primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility.

High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

31.12.2021: Recent Omicron articles

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

25.12.2021: Recent Omicron preprint articles

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak

A Bivalent Nanoparticle Vaccine Exhibits Potent Cross-protection against the Variants of SARS-CoV-2

Identifying infectiousness of SARS-CoV-2 by ultra-sensitive SnS2 SERS biosensors with capillary effect

20.12.2021: Recent Omicron preprint articles

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

The combined treatment of Molnupiravir and Favipiravir results in a marked potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

16.12.2021: Recent Omicron preprint articles

Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum

SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization

SARS-CoV-2 T cell responses are expected to remain robust against Omicron

Mutations in RBD of SARS-CoV-2 Omicron variant result stronger binding to human ACE2 protein

Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

14.12.2021: My recent selection on COVID-19

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

Protection against Covid-19 by BNT162b2 Booster across Age Groups

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

A Single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response

15.09.2021: My recent selection on COVID-19

A third dose reduced recipients’ risk of testing positive for SARS-CoV-2 by more than 10-fold

Decline in Pathogenic Antibodies over Time in VITT

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

02.05.2021: My April's selection on COVID-19

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries

Post-acute COVID-19 syndrome

Vaccine development for emerging infectious diseases

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection

Right Heart Strain on Presenting 12-Lead Electrocardiogram Predicts Critical Illness in COVID-19

02.03.2021

Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomized trials

18.02.2021

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2

Hydrating the Respiratory Tract: An Alternative Explanation Why Masks Lower Severity of COVID-19

Prospects of Nutritional Interventions in the Care of COVID-19 Patients

02.02.2021

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomized controlled phase 3 trial in Russia

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

Humoral Immune Response to SARS-CoV-2 in Iceland

Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

Type I interferon, anti-interferon antibodies, and COVID-19

Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19

10.01.2021

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Maintaining Safety with SARS-CoV-2 Vaccines

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

12.12.2020

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

How kids’ immune systems can evade COVID

Genetic mechanisms of critical illness in Covid-19

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses

Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test

25.11.2020

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Wearable sensor data and self-reported symptoms for COVID-19 detection

False-positive COVID-19 results: hidden problems and costs

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

Insulin treatment is associated with increased mortality in patients with COVID-19

10.11.2020

Patient-facing healthcare workers had threefold increased risk and their household members twofold increased risk for admission with COVID-19.

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Pfizer And Biontech Announce Vaccine Candidate Against Covid-19 Achieved Success in First Interim Analysis from Phase 3 Study

20.10.2020

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations

Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries

Integrative transcriptome analyses empower the anti-COVID-19 drug arsenal

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis

05.10.2020

SARS-CoV-2 RapidPlex: A Graphene-based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

COVID-19: Trump's Treatment / Vaccine Priority / Face Mask Safety / Multisystem Inflammatory Syndrome in Adults / Remdesivir & Kidney Injury

24.09.2020

Convalescent plasma treatment of severe COVID-19:

a propensity score–matched control study

Seasonal coronavirus protective immunity is short-lasting

Clinical features of COVID-19 mortality:

development and validation of a clinical prediction model

Deep learning-based triage and analysis of lesion burden for COVID-19: a retrospective study with external validation

Electrocardiographic Changes and Arrhythmias in Hospitalized Patients with Coronavirus Disease (COVID-19)

Arrhythmic Complications of Patients Hospitalized with COVID-19: Incidence, Risk Factors and Outcomes

01.09.2020

Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19

Cardiac Troponin for Assessment of Myocardial Injury in COVID-19

23.08.2020

The Interpretation of SARS-CoV-2 Diagnostic Tests

Metformin Use Is Associated with Increased Incidence of Acidosis but not Mortality in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2

15.08.2020

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicenter observational study

The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature

10.08.2020

Anakinra for severe forms of COVID-19: 1

Anakinra for severe forms of COVID-19: 2

Anakinra for severe forms of COVID-19: 3

Systems-level immunomonitoring from acute to recovery phase of severe COVID-19

Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19

30.07.2020

Immunothrombotic Dysregulation in COVID-19 Pneumonia is Associated with Respiratory Failure and Coagulopathy

Extrapulmonary manifestations of COVID-19

Digital tools against COVID-19: taxonomy, ethical challenges, and navigation aid

Applications of digital technology in COVID-19 pandemic planning and response

25.07.2020

Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study

Particle sizes of infectious aerosols: implications for infection control

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

21.07.2020

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomized, double-blind, placebo-controlled, phase 2 trial

21.07.2020

16.07.2020

The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.

COVID-19: Myocardial injury in survivors

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Ramipril in High-Risk Patients With COVID-19

10.07.2020

COVID-19, Arrhythmic Risk, and Inflammation

Effects of lockdown on human sleep and chronotype during the COVID-19 pandemic

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

The Science Underlying COVID-19: Implications for the Cardiovascular System

03.07.2020

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

Novel use of home pulse oximetry monitoring in COVID‐19 patients discharged from the emergency department identifies need for hospitalization

30.06.2020

Considering how biological sex impacts immune responses and COVID-19 outcomes

27.06.2020

COVID-19 in children and adolescents in Europe: a multinational, multicenter cohort study

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

20.06.2020

COVID-19 Research in Brief: 13 June to 19 June 2020

Genome-wide Association Study of Severe Covid-19 with Respiratory Failure

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-center, prospective cohort study

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

16.06.2020

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

14.06.2020

COVID-19 Research in Brief: 6 June to 12 June, 2020

12.06.2020

JACC State-of-the-Art Review

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

JACC Review Topic of the Week

Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic

Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 

COVID-19: from epidemiology to treatment 

11.06.2020

Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2

07.06.2020

Prevalence of Asymptomatic SARS-CoV-2 Infection

06.06.2020

Nature: COVID-19 Research in Brief: 30 May to 5 June, 2020

05.06.2020

False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

01.06.2020

High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19

Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19

Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?

01.06.2020

SCIENCE: Reducing transmission of SARS-CoV-2

LANCET: Physical distancing, face masks, and eye protection for prevention of COVID-19

30.05.2020

NATURE: COVID-19 Research in Brief: 23 May to 29 May, 2020

NATURE: COVID-19 Research in Brief: 16 May to 22 May, 2020

29.05.2020

Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

COVID-19: Asymptomatic Infection / Stay-at-Home Orders / Racial Differences / Remdesivir Treatment Duration

26.05.2020

Pathogenesis of SARS-CoV-2 in transgenic mice expressing human ACE2

24.05.2020

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, nonrandomized, first-in-human trial

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Artificial intelligence–enabled rapid diagnosis of patients with COVID-19

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

23.05.2020

Remdesivir for the Treatment of Covid-19

22.05.2020

Coronaviruses and the cardiovascular system: acute and long-term implications

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Deleterious effects of viral pneumonia on cardiovascular system 

Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

Severe Covid-19

How to Discover Antiviral Drugs Quickly

16.05.2020

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

COVID-19 Research in Brief: 9 May to 15 May, 2020

15.05.2020

Cardiac and arrhythmic complications in patients with COVID‐19

11.05.2020

COVID-19 Research in Brief: 2 May to 8 May 2020

Modeling shield immunity to reduce COVID-19 epidemic spread

Antibody responses to SARS-CoV-2 in patients with COVID-19

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomized, phase 2 trial

08.05.2020

Early Self‐Proning in Awake, Non‐intubated Patients in the Emergency Department

COVID-19: consider cytokine storm syndromes and immunosuppression

Hyperinflammatory shock in children during COVID-19 pandemic

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

05.05.2020

Establishment and Management of Mechanical Circulatory Support During the COVID-19 Pandemic

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

01.05.2020

Emergency Use Authorization for use of Remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients

There was no evidence that ACE inhibitors or ARBs affected the risk of COVID-19

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

COVID-19 Research in Brief: 24 April to 1 May, 2020

30.04.2020

Neurologic Features in Severe SARS-CoV-2 Infection

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington

29.04.2020

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

26.04.2020

In hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB is associated with lower risk of all-cause mortality compared with ACEI/ARB non-users.

Therapeutic Remdesivir treatment initiated early during infection has a clear clinical benefit in SARS-CoV-2-infected rhesus macaques.

COVID-19 Research in Brief: 18 April to 24 April, 2020.

Infection-control strategies focused solely on symptomatic patients are not sufficient to prevent transmission after SARS-CoV-2 introduction.

Mild or Moderate Covid-19 Infection.

24.04.2020

Computers and Viral Diseases: Preliminary Bioinformatics Studies on the Design of a Synthetic Vaccine and a Preventative Peptidomimetic Antagonist Against the SARS-CoV-2 (2019-nCoV, COVID-19) Coronavirus

Inhibition of SARS-CoV-2 Infection by a Highly Potent Pan-Coronavirus Fusion Inhibitor Targeting Its Spike Protein That Harbors a High Capacity to Mediate Membrane Fusion

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

20.04.2020

COVID-19 Research in Brief: 11 April to 17 April, 2020

19.04.2020

Video: How to Obtain a Nasopharyngeal Swab Specimen

Universal Masking in Hospitals in the Covid-19 Era

SARS-CoV-2 and viral sepsis: observations and hypotheses

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study

18.04.2020

COVID-19 and Cardiovascular Medicine:

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings

The Science Underlying COVID-19: Implications for the Cardiovascular System

COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap!

Reperfusion of STEMI in the COVID-19 Era - Business as Usual?

17.04.2020

COVID-19: the case for health-care worker screening to prevent hospital transmission

Estimates of the severity of coronavirus disease 2019: a model-based analysis

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

COVID-19-Therapie: Erkenntnisse und Hypothesen

Nature COVID-19 Research in Brief: 4 April to 10 April 2020

Temporal dynamics in viral shedding and transmissibility of COVID-19

11.04.2020

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Trials of anti-tumor necrosis factor therapy for COVID-19 are urgently needed

10.04.2020

Audio Interview: Emerging Tools in the Fight against Covid-19

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Covid-19 and Health Care’s Digital Revolution

Covid-19 in South Korea — Challenges of Subclinical Manifestations

First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment

06.04.2020

COVID-19, Troponin T Levels, and Prognosis: An Early Look

Clinical characteristics of 113 deceased patients with COVID-19: retrospective study

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus infected pneumonia (standard version).

Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients.

05.04.2020

Digitizing contact tracing through a mobile-phone app may achieve sustainable epidemic suppression

COVID-19 Research in Brief: 28 March to 3 April, 2020

Respiratory virus shedding in exhaled breath and efficacy of face masks

COVID-19 interim Guidelines:

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Clinical management of severe acute respiratory infection when COVID-19 is suspected

04.04.2020

COVID-19 is a Data Science Issue

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

SARS-CoV-2 vaccines: status report

A dynamic immune response shapes COVID-19 progression

Ongoing Clinical Trials for the Management of the COVID-19 Pandemic

03.04.2020

COVID-19 and Cardiovascular Medicine:

Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in China

Potential Effects of Coronaviruses on the Cardiovascular System

Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

25.03.2020

COVID-19 and Cardiovascular Medicine:

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI

Coronaviruses and the cardiovascular system: acute and long-term implications

Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience from Milan, Italy